Table 3 Response rate observed in the global case series and according to treatment received (lipiodol TACE or pTACE) (CR = complete remission; PR = partial remission; SD = stable disease; PD = progressive disease NA = not available)
Objective response | |||
|---|---|---|---|
TACE lipiodol | pTACE microspheres | Total | |
CR (%) | 17 (20) | 14 (24) | 31 (22) |
PR (%) | 32 (39) | 19 (33) | 51 (36) |
SD (%) | 16 (19) | 7 (12) | 23 (15) |
PD (%) | 18 (22) | 18 (31) | 36 (27) |
NA | 8 | 1 | 9 |